Submitted by Anonymous (not verified) on 3 September 2025 - 9:35
Human medicines European public assessment report (EPAR): Tibsovo, ivosidenib, Date of authorisation: 04/05/2023, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tibsovo, ivosidenib, Date of authorisation: 04/05/2023, Revision: 4, Status: Authorised